ONOle Norgaard

Ole Norgaard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ole Norgaard has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Continuous Glucose Monitoring–Derived Metrics and Cardiovascular Risk Among People With Diabetes: Systematic Scoping Review

    by Helene Bei Thomsen, Benjamin Lebiecka-Johansen, Ole Nørgaard, Tue Helms Andersen, Signe Toft Andersen, Guy Fagherazzi, Adam Hulman, Anders Aasted Isaksen

    Background: Conventional clinical markers guide cardiovascular risk stratification; however, continuous glucose monitoring (CGM) data remain absent from prediction models. A synthesis of the current literature is needed to clarify the prognostic relevance of CGM data for cardiovascular outcomes in people with diabetes. Objective: This scoping review aimed to identify published studies examining (1) the associations between glycemic control and cardiovascular outcomes and (2) the predictive value of CGM-derived metrics in cardiovascular risk assessment. Methods: MEDLINE and Embase were searched from inception to March 11, 2025, for peer-reviewed, original research that included CGM-derived metrics and cardiovascular disease (CVD) outcomes. Two reviewers screened the records independently. Results: A total of 53 studies were identified. These studies focused on type 1 diabetes, type 2 diabetes, both diabetes types, or prediabetes. Clinical outcomes were examined in 16 studies, while subclinical outcomes were assessed in 40 studies. Of the 53 studies, 47 were cross-sectional studies and 6 were longitudinal studies. All studies were association studies, and 3 included secondary analyses of predictive performance. However, none applied machine learning–based methods. A wide range of CGM-derived metrics and CVD outcomes, both clinical and subclinical, were studied in the literature. Conclusions: Overall, the findings were inconsistent across studies, and this was likely due to methodological weaknesses such as underpowered analyses. Time-in-range was both the most studied metric and associated with cardiovascular risk in the largest single study. Only the mean amplitude of glycemic excursions was consistently associated with CVD in most studies investigating this metric, when using statistical significance as a pragmatic indicator of consistency across heterogeneous studies. The prognostic value of CGM-derived metrics for CVD outcomes is currently underexplored. Longitudinal prediction studies on clinical CVD outcomes, leveraging the potential of routinely collected CGM data, are needed.


  • Open Access

    Revisiting insulin resistance in human cancer cachexia – a systematic review and meta-analysis

    by Jonas Sørensen, Anna Hammershøi, Joan Miquel Màrmol, Louise Lang Lehrskov, Ole Nørgaard, Lykke Sylow

    Background: In patients with cancer, unintentional weight loss and cancer-associated cachexia (CAC) reduce overall survival and impair the quality of life. Because of insulin’s anabolic effects, insulin resistance could contribute to CAC progression. However, the role of insulin resistance in CAC remains unclear, and this study aimed to investigate the association between insulin resistance and CAC. Addressing this knowledge gap may help identify treatable targets to improve patient outcomes. Methods: We performed a systematic review and meta-analysis. By including studies reporting both fasting levels of circulating insulin and glucose in patients with cancer and CAC according to the internationally accepted CAC definition, we calculated the HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) index to estimate the level of insulin resistance (defined as HOMA-IR above 2.0) in patients with CAC. A subgroup analysis was conducted from studies reporting a HOMA-IR index both from a group of patients with CAC and a group without CAC (nonCAC). Results: Seventeen studies were included, with a total of 197 patients. The mean HOMA-IR of all studies was 1.84 (95% confidence interval [CI]: 1.77–1.91). Twelve studies found HOMA-IR below 2.0. Five of the 17 studies also reported HOMA-IR from a group of patients with cancer without CAC. We observed a mean difference of −0.42 (95% CI: −2.24 to 1.40) in favour of a lower HOMA-IR in patients with CAC compared to nonCAC, and thus no statistically significant difference between the groups. Interpretation: This systematic review suggests no clear association between insulin resistance and CAC. However, the limited sample sizes and study heterogeneity highlight the need for larger, longitudinal investigations.

  • Open Access

    Using Artificial Intelligence Tools as Second Reviewers for Data Extraction in Systematic Reviews: A Performance Comparison of Two AI Tools Against Human Reviewers

    by T. Helms Andersen, T. M. Marcussen, A. D. Termannsen, T. W. H. Lawaetz, O. Nørgaard

    Background: Systematic reviews are essential but time‐consuming and expensive. Large language models (LLMs) and artificial intelligence (AI) tools could potentially automate data extraction, but no comprehensive workflow has been tested for different review types. Objective: To evaluate Elicit's and ChatGPT's abilities to extract data from journal articles as a replacement for one of two human data extractors in systematic reviews. Methods: Human‐extracted data from three systematic reviews (30 articles in total) was compared to data extracted by Elicit and ChatGPT. The AI tools extracted population characteristics, study design, and review‐specific variables. Performance metrics were calculated against human double‐extracted data as the gold standard, followed by a detailed error analysis. Results: Precision, recall and F1‐score were all 92% for Elicit and 91%, 89% and 90% for ChatGPT. Recall was highest for study design (Elicit: 100%; ChatGPT: 90%) and population characteristics (Elicit: 100%; ChatGPT: 97%), while review‐specific variables achieved 77% in Elicit and 80% in ChatGPT. Elicit had four instances of confabulation while ChatGPT had three. There was no significant difference between the two AI tools' performance (recall difference: 3.3% points, 95% CI: –5.2%–11.9%, p = 0.445). Conclusion: AI tools demonstrated high and similar performance in data extraction compared to human reviewers, particularly for standardized variables. Error analysis revealed confabulations in 4% of data points. We propose adopting AI‐assisted extraction to replace the second human extractor, with the second human instead focusing on reconciling discrepancies between AI and the primary human extractor.


  • Open Access

    Revisiting insulin resistance in human cancer cachexia – a systematic review and meta-analysis

    by Jonas Sørensen, Anna Hammershøi, Joan Miquel Màrmol, Louise Lang Lehrskov, Ole Nørgaard, Lykke Sylow

    Background: Approximately half of all patients with cancer experience unintentional weight loss called cancer cachexia (CAC), which reduces overall survival and impairs quality of life. Metabolic dysfunction is frequently observed in patients with cancer, likely due to insulin resistance. Due to its anabolic effects, insulin resistance could be implicated in the progression of CAC. However, comprehensive clinical data in human populations remain limited, and the potential association between insulin resistance and CAC has yet to be clearly established. Covering this knowledge gap will guide our search for treatable targets to alleviate patients in the future. Methods: To address this knowledge gap, we performed a systematic review and meta-analysis, including comprehensive searches in MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL). By including studies reporting both fasting levels of insulin and glucose in patients with cancer and CAC according to the internationally accepted CAC definition, we calculated HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) index for each study and thereby estimated the level of insulin resistance (defined as HOMA-IR above 2.0) in patients with CAC. A subgroup analysis was conducted from studies reporting a HOMA-IR index both from a group of patients with CAC and a group of patients without CAC (non-CAC). Results: The mean HOMA-IR of all studies was 1.84 (95%CI: 1.77-1.91). Seventeen studies, with a total of 197 patients with CAC, conducted from 1982 to 2007, fulfilled the inclusion criteria. Age ranged from 52 to 68 years. Five studies reported a HOMA-IR above 2.0, indicative of insulin resistance. Twelve studies found HOMA-IR below 2.0. No differences between disease- or patient characteristics between the studies reporting HOMA-IR values above 2.0 vs. those below 2.0 were identified. Five of the 17 studies also reported HOMA-IR from a group of patients with cancer without CAC, allowing for a separate meta-analysis. In 37 patients with CAC and 49 patients without CAC we documented a mean difference of -0.42 (95%CI: -2.24-1.40) in favor of a lower HOMA-IR in patients with CAC compared to without CAC. Heterogeneity between studies was significant with I 2 =□94% (P□<□0.05). Conclusions: This systematic review indicates that insulin resistance in patients with cancer and cachexia does not manifest to the same extent as in cancer populations without cachexia. These findings challenge the prevailing understanding of insulin resistance as a driver of cancer cachexia and underscore the need for further longitudinal research in this area.


  • Open Access

    Prediction of Cardiovascular Markers and Diseases Using Retinal Fundus Images and Deep Learning: A Systematic Scoping Review

    by Livie Yumeng Li, Anders Aasted Isaksen, Benjamin Lebiecka-Johansen, Kristian Funck, Vajira Thambawita, Stine Byberg, Tue Helms Andersen, Ole Norgaard, Adam Hulman

    Background Cardiovascular risk prediction models based on sociodemographic factors and traditional clinical measurements have received significant attention. With rapid development in deep learning for image analysis in the last decade and the well-known association between micro- and macrovascular complications, some recent studies focused on the prediction of cardiovascular risk using retinal fundus images. The objective of this scoping review is to identify and describe studies using retinal fundus images and deep learning to predict cardiovascular risk markers and diseases. Methods We searched MEDLINE and Embase for peer-reviewed articles on 17 November 2023. Abstracts and relevant full-text articles were independently screened by two reviewers. We included studies that used deep learning for the analysis of retinal fundus images to predict cardiovascular risk markers (e.g. blood pressure, coronary artery calcification, intima-media thickness) or cardiovascular diseases (prevalent or incident). Studies that used only predefined characteristics of retinal fundus images (e.g. tortuosity, fractal dimension) were not considered. Study characteristics were extracted by the first author and verified by the senior author. Results are presented using descriptive statistics. Results We included 24 articles in the review, published between 2018 and 2023. Among these, 21 (88%) were cross-sectional studies and eight (33%) were follow-up studies with outcome of clinical CVD. Five studies included a combination of both designs. Most studies (n=23, 96%) used convolutional neural networks to process images. We found nine (38%) studies that incorporated clinical risk factors in the prediction and four (17%) that compared the results to commonly used clinical risk scores in a prospective setting. Three of these reported improved discriminative performance. External validation of models was rare (n=5, 21%). Only four (17%) studies made their code publicly available. Conclusions There is an increasing interest in using retinal fundus images in cardiovascular risk assessment. However, there is a need for more prospective studies, comparisons of results to clinical risk scores and models augmented with traditional risk factors. Moreover, more extensive code sharing is necessary to make findings reproducible and more impactful beyond a specific study.


  • Open Access

    Information needs for GPs on type 2 diabetes in Western countries: a systematic review

    by Tue Helms Andersen, Thomas Møller Marcussen, Ole Nørgaard

    Background: Most people with type 2 diabetes receive treatment in primary care by GPs who are not specialised in diabetes. Thus, it is important to uncover the most essential information needs regarding type 2 diabetes in general practice.Aim: To identify information needs related to type 2 diabetes for GPs.Design and setting: Systematic review focused on literature relating to Western countries.Method: MEDLINE, Embase, PsycInfo and CINAHL were searched from inception to January 2024. Two researchers conducted the selection process, and citation searches were performed to identify any relevant articles missed by the database search. Quality appraisal was conducted with the Mixed Methods Appraisal Tool. Meaning units were coded individually, grouped into categories, and then studies were summarised within the context of these categories using narrative synthesis. An evidence map was created to highlight research gaps.Results: Thirty-nine included studies revealed eight main categories and 36 subcategories of information needs. Categories were organised into a comprehensive hierarchical model of information needs, suggesting ‘Knowledge of guidelines’ and ‘Reasons for referral’ as general information needs alongside more specific needs on ‘Medication’, ‘Management’, ‘Complications’, ‘Diagnosis’, ‘Risk factors’, and ‘Screening for diabetes’. The evidence map provides readers with the opportunity to explore the characteristics of the included studies in detail.Conclusion: This systematic review provides GPs, policymakers, and researchers with a hierarchical model of information and educational needs for GPs, and an evidence map showing gaps in the current literature. Information needs about clinical guidelines and reasons for referral to specialised care overlapped with needs for more specific information.


  • Open Access

    Feasibility of time‐restricted eating in individuals with overweight, obesity, prediabetes, or type 2 diabetes: A systematic scoping review

    by Anne‐Ditte Termannsen, Annemarie Varming, Christina van Elst, Natasja Bjerre, Ole Nørgaard, Nana Folmann Hempler, Kristine Færch, Jonas Salling Quist

    Objective: This systematic scoping review aimed to map and synthesize research on feasibility of time‐restricted eating (TRE) in individuals with overweight, obesity, prediabetes, or type 2 diabetes, including recruitment rate, retention rate, safety, adherence, and participants' attitudes, experiences, and perspectives.Methods: The authors searched MEDLINE, Embase, and Cumulative Index to Nursing and Allied Health Literature from inception to November 22, 2022, supplemented by backward and forward citation search.Results: From 4219 identified records, 28 studies were included. In general, recruitment was easy and median retention rate was 95% among studies with <12 weeks duration and 89% among studies ≥12 weeks. Median (range) adherence to the target eating window for studies <12 and ≥12 weeks was 89% (75%–98%) and 81% (47%–93%), respectively. Variation in adherence among participants and studies was considerable, indicating that following TRE was difficult for some people and that intervention conditions influenced adherence. These findings were supported by qualitative data synthetized from seven studies, and determinants of adherence included calorie‐free beverages outside the eating window, provision of support, and influence on the eating window. No serious adverse events were reported.Conclusions: TRE is implementable, acceptable, and safe in populations with overweight, obesity, prediabetes, or type 2 diabetes, but it should be accompanied by support and options for individual adjustments.


  • Insulin resistance in patients with cancer: a systematic review and meta-analysis

    by Joan M. Màrmol, Michala Carlsson, Steffen H. Raun, Mia K. Grand, Jonas Sørensen, Louise Lang Lehrskov, Erik A. Richter, Ole Norgaard, Lykke Sylow

    Insulin resistance is a critical cause of metabolic dysfunctions. Metabolic dysfunction is common in patients with cancer and is associated with higher cancer recurrence rates and reduced overall s...


  • Open Access

    Effects of vegan diets on cardiometabolic health: A systematic review and meta‐analysis of randomized controlled trials

    by Anne‐Ditte Termannsen, Kim Katrine Bjerring Clemmensen, Jonas Mark Thomsen, Ole Nørgaard, Lars Jorge Díaz, Signe Sørensen Torekov, Jonas Salling Quist, Kristine Færch

    Summary: In parallel with an increased focus on climate changes and carbon footprint, the interest in plant‐based diets and its potential health effects have increased over the past decade. The objective of this systematic review and meta‐analysis was to examine the effect of vegan diets (≥12 weeks) on cardiometabolic risk factors in people with overweight or type 2 diabetes. We identified 11 trials (796 participants). In comparison with control diets, vegan diets reduced body weight (−4.1 kg, 95% confidence interval (CI) −5.9 to −2.4, p < 0.001), body mass index (BMI) (−1.38 kg/m2, 95% CI −1.96 to −0.80, p < 0.001), glycated hemoglobin (HbA1c) (−0.18% points, 95% CI −0.29 to −0.07, p = 0.002), total cholesterol (−0.30 mmol/L, 95% CI −0.52 to −0.08, p = 0.007), and low‐density lipoprotein cholesterol (−0.24 mmol/L, 95% CI −0.40 to −0.07, p = 0.005). We identified no effect on blood pressure, high‐density lipoprotein cholesterol, and triglycerides. We found that adhering to vegan diets for at least 12 weeks may be effective in individuals with overweight or type 2 diabetes to induce a meaningful decrease in body weight and improve glycemia. Some of this effect may be contributed to differences in the macronutrient composition and energy intake in the vegan versus control diets. Therefore, more research is needed regarding vegan diets and cardiometabolic health.


  • Open Access

    Seeking a deeper understanding of ‘distributed health literacy’: A systematic review

    by Danielle M. Muscat, Danielle Gessler, Julie Ayre, Ole Norgaard, Iben R. Heuck, Stefanie Haar, Helle T. Maindal

    Background: Previous research suggests that it would be useful to view health literacy as a set of ‘distributed competencies’, which can be found dispersed through the individual's social network, rather than an exclusively individual attribute. However, to date there is no focused exploration of how distributed health literacy has been defined, conceptualized or assessed in the peer‐reviewed literature.Aims: This systematic review aimed to explore: (1) definitions and conceptual models of distributed health literacy that are available from the peer‐reviewed literature; and (2) how distributed health literacy has been measured in empirical research.Methods: We searched MEDLINE, Embase, CINAHL, PsycInfo, Scopus, ERIC and Web of Science using truncated versions of the keywords ‘literacy’ and ‘distributed’ (within five words' distance). We collated the definitions and conceptual models of distributed health literacy, and report on how health literacy has been measured in empirical research studies. Findings related to distributed health literacy from included manuscripts were synthesized using thematic synthesis.Results: Of the 642 studies screened, 10 were included in this systematic review. The majority were empirical manuscripts reporting on qualitative research in one of five countries, with two reviews, one conceptual analysis and one quantitative study. Edwards' definition of distributed health literacy, which emphasizes the health literacy abilities, skills and practices of others that contribute to an individual's level of health literacy was widely applied in a variety of clinical and geographical settings. However, we did not identify any quantitative instruments which directly measured distributed health literacy. There was significant variability in questions used to explore the concept qualitatively, and discrepancies across studies in regard to (a) what constitutes distributed health literacy and what does not (e.g., general social support), and (b) the relationship between distributed health literacy and other constructs (e.g., public health literacy).Conclusion: Although there is a widely applied definition of distributed health literacy, our review revealed that the research space would benefit from the development of the concept, both theoretically for example via conceptual distinctions between distributed health literacy and other types of social support, and empirically for example through the development of a quantitative measurement instrument.Patient or Public Contribution: This paper is a systematic review and did not involve patients or the public.